Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Stereotactic radiosurgery practice patterns for brain metastases in the United States: a national survey.

Blomain ES, Kim H, Garg S, Bhamidipati D, Guo J, Kalchman I, McAna J, Shi W.

J Radiat Oncol. 2018 Sep;7(3):241-246. doi: 10.1007/s13566-018-0353-8. Epub 2018 May 11.

2.

Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.

Shi W, Blomain ES, Siglin J, Palmer JD, Dan T, Wang Y, Werner-Wasik M, Glass J, Kim L, Bar Ad V, Bhamidipati D, Evans JJ, Judy K, Farrell CJ, Andrews DW.

J Neurooncol. 2018 Mar;137(1):179. doi: 10.1007/s11060-018-2744-5.

PMID:
29313182
3.

Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.

Shi W, Blomain ES, Siglin J, Palmer JD, Dan T, Wang Y, Werner-Wasik M, Glass J, Kim L, Bar Ad V, Bhamidipati D, Evans JJ, Judy K, Farrell CJ, Andrews DW.

J Neurooncol. 2018 Mar;137(1):171-177. doi: 10.1007/s11060-017-2709-0. Epub 2017 Dec 12. Erratum in: J Neurooncol. 2018 Jan 8;:.

PMID:
29235052
4.

Guanylyl cyclase C signaling axis and colon cancer prevention.

Pattison AM, Merlino DJ, Blomain ES, Waldman SA.

World J Gastroenterol. 2016 Sep 28;22(36):8070-7. doi: 10.3748/wjg.v22.i36.8070. Review.

5.

Intestinal Enteroids Model Guanylate Cyclase C-Dependent Secretion Induced by Heat-Stable Enterotoxins.

Pattison AM, Blomain ES, Merlino DJ, Wang F, Crissey MA, Kraft CL, Rappaport JA, Snook AE, Lynch JP, Waldman SA.

Infect Immun. 2016 Sep 19;84(10):3083-91. doi: 10.1128/IAI.00639-16. Print 2016 Oct.

6.

Guanylyl Cyclase C Hormone Axis at the Intersection of Obesity and Colorectal Cancer.

Blomain ES, Merlino DJ, Pattison AM, Snook AE, Waldman SA.

Mol Pharmacol. 2016 Sep;90(3):199-204. doi: 10.1124/mol.115.103192. Epub 2016 Jun 1. Review.

7.

Role of muscarinic-3 receptor antibody in systemic sclerosis: correlation with disease duration and effects of IVIG.

Kumar S, Singh J, Kedika R, Mendoza F, Jimenez SA, Blomain ES, DiMarino AJ, Cohen S, Rattan S.

Am J Physiol Gastrointest Liver Physiol. 2016 Jun 1;310(11):G1052-60. doi: 10.1152/ajpgi.00034.2016. Epub 2016 May 12.

8.

GUCY2C ligand replacement to prevent colorectal cancer.

Blomain ES, Pattison AM, Waldman SA.

Cancer Biol Ther. 2016 Jul 2;17(7):713-8. doi: 10.1080/15384047.2016.1178429. Epub 2016 Apr 22. Review.

9.

Does obesity promote the development of colorectal cancer?

Blomain ES, Waldman SA.

Expert Rev Anticancer Ther. 2016 May;16(5):465-7. doi: 10.1586/14737140.2016.1162102. Epub 2016 Mar 24. No abstract available.

10.

A novel CDX2 isoform regulates alternative splicing.

Witek ME, Snook AE, Lin JE, Blomain ES, Xiang B, Magee MS, Waldman SA.

PLoS One. 2014 Aug 7;9(8):e104293. doi: 10.1371/journal.pone.0104293. eCollection 2014. Erratum in: PLoS One. 2014;9(10):e112164. Magee, Michael [corrected to Magee, Michael S].

11.

Tumor radiation therapy creates therapeutic vaccine responses to the colorectal cancer antigen GUCY2C.

Witek M, Blomain ES, Magee MS, Xiang B, Waldman SA, Snook AE.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1188-95. doi: 10.1016/j.ijrobp.2013.12.043.

12.

Mechanisms of Weight Regain following Weight Loss.

Blomain ES, Dirhan DA, Valentino MA, Kim GW, Waldman SA.

ISRN Obes. 2013 Apr 16;2013:210524. doi: 10.1155/2013/210524. eCollection 2013. Review.

13.

Gut-Brain Endocrine Axes in Weight Regulation and Obesity Pharmacotherapy.

Merlino DJ, Blomain ES, Aing AS, Waldman SA.

J Clin Med. 2014 Jul 15;3(3):763-94. doi: 10.3390/jcm3030763. Review.

14.

Antiobesity pharmacotherapy: new drugs and emerging targets.

Kim GW, Lin JE, Blomain ES, Waldman SA.

Clin Pharmacol Ther. 2014 Jan;95(1):53-66. doi: 10.1038/clpt.2013.204. Epub 2013 Oct 8. Review.

15.

Intestinal GUCY2C prevents TGF-β secretion coordinating desmoplasia and hyperproliferation in colorectal cancer.

Gibbons AV, Lin JE, Kim GW, Marszalowicz GP, Li P, Stoecker BA, Blomain ES, Rattan S, Snook AE, Schulz S, Waldman SA.

Cancer Res. 2013 Nov 15;73(22):6654-66. doi: 10.1158/0008-5472.CAN-13-0887. Epub 2013 Oct 1.

16.

Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis.

Blomain ES, Lin JE, Kraft CL, Trela UT, Rock JM, Aing AS, Snook AE, Waldman SA.

Expert Rev Clin Pharmacol. 2013 Sep;6(5):557-64. doi: 10.1586/17512433.2013.827406. Epub 2013 Aug 24. Review.

17.

New advances in models and strategies for developing anti-obesity drugs.

Kim GW, Lin JE, Blomain ES, Waldman SA.

Expert Opin Drug Discov. 2013 Jun;8(6):655-71. doi: 10.1517/17460441.2013.792804. Epub 2013 Apr 29. Review.

18.

Selective RAF inhibitor impairs ERK1/2 phosphorylation and growth in mutant NRAS, vemurafenib-resistant melanoma cells.

Le K, Blomain ES, Rodeck U, Aplin AE.

Pigment Cell Melanoma Res. 2013 Jul;26(4):509-17. doi: 10.1111/pcmr.12092. Epub 2013 Apr 8.

19.

Dynamic regulation of mitochondrial transcription as a mechanism of cellular adaptation.

Blomain ES, McMahon SB.

Biochim Biophys Acta. 2012 Sep-Oct;1819(9-10):1075-9. doi: 10.1016/j.bbagrm.2012.06.004. Epub 2012 Jul 3. Review.

Supplemental Content

Loading ...
Support Center